Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Mar 31, 2025, 4:00 PM
1.220
+0.020 (1.67%)
After-hours: Mar 31, 2025, 5:33 PM EDT
Aytu BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aytu BioPharma.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aytu BioPharma.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +316.67% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,566.67% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +9,900.00% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +8,233.33% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +18,233.33% | Apr 28, 2022 |
Financial Forecast
Revenue This Year
68.45M
from 81.00M
Decreased by -15.50%
Revenue Next Year
74.02M
from 68.45M
Increased by 8.14%
EPS This Year
0.73
from -2.86
EPS Next Year
1.40
from 0.73
Increased by 90.28%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.5M | 76.2M | 77.6M | ||
| Avg | 68.4M | 74.0M | 75.4M | ||
| Low | 65.8M | 71.1M | 72.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -13.0% | 11.3% | 4.9% | ||
| Avg | -15.5% | 8.1% | 1.9% | ||
| Low | -18.8% | 3.9% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.76 | 1.44 | 1.46 |
| Avg | 0.73 | 1.40 | 1.42 |
| Low | 0.71 | 1.34 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 95.9% | 4.4% |
| Avg | - | 90.3% | 1.5% |
| Low | - | 82.8% | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.